Lamivudine
Indication
Hepcidin (lamivudine tablets) is indicated for the treatment of adult chronic hepatitis B patients with compensated liver function accompanied by elevated alanine aminotransferase [ALT] and viral activity replication.
Manufacturer
Lianyungang Runzhong Pharmaceutical Co., Ltd.
-
Founded in:
2010-10-20 -
Address:
No. 16, Jinqiao Road, Dapu Industrial Zone, Lianyungang Economic and Technological Development Zone -
Tax NO.:
913207005629851634 -
Registered Funds:
103.528805 yuan -
Email: